Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_2023_Capital_increase_EN_espi.pdf New capital of "Sopharma" AD entered in the Commercial Register

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 183 / 2023
Date of issue: 2023-10-06
Short name of the issuer
SOPHARMA AD
Subject
New capital of "Sopharma" AD entered in the Commercial Register
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) notifies that as a result of the conditional capital increase through the exercise of warrants from an issue with ISIN BG9200001212 the new capital of "Sopharma" AD amounting to BGN 172,590,578 was entered in the Commercial Register, under number 20231006154857.

A procedure for registration of the new issue in the registers of the Financial Supervision Commission and "Central Depository" AD and the admission of the shares from the increase to trading on "Bulgarian Stock Exchange" AD is pending.
Annexes
File Description
SFA_2023_Capital_increase_EN_espi.pdf
SFA_2023_Capital_increase_EN_espi.pdf		 New capital of "Sopharma" AD entered in the Commercial Register

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-10-06 Ognian Donev Executive Director
20231006_163634_1508459988_SFA_2023_Capital_increase_EN_espi.pdf

Pobierz